Hemant Surgical Industries Reports Strong H1 FY27 Performance with Significant Revenue and Profit Growth
Hemant Surgical Industries Ltd · Outcome · 14 Nov 2026, 9:37 pm
Hemant Surgical Industries Reports Strong H1 FY27 Performance with Significant Revenue and Profit Growth Hemant Surgical Industries reported a standout H1 ended 30th Sep'26, with consolidated revenue surging 327.59% YoY to ₹27,631.06 lakhs compared to ₹6,462.01 lakhs in H1 ended 30th Sep'25. Consolidated net profit rose 245.03% YoY to ₹1,883.82 lakhs from ₹545.98 lakhs, driving basic EPS to ₹13.30 from ₹5.15. On a standalone basis, revenue reached ₹27,592.01 lakhs and net profit hit ₹1,911.75 lakhs. The group acquired a 66.66% stake in Lifesenz Cancer Research Labs on 1st Jun'26 for ₹1,999.80 lakhs.
Original exchange filing (PDF)
More announcements from Hemant Surgical Industries Ltd
- Unaudited Financial Results (standalone and consolidated) of the Company for half year ended September 30, 2026. · 14 Nov 2026
- Hemant Surgical Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2026 ,inter alia, to consider and approve Unaudited Financial .... · 14 Nov 2026
- Scrutinizer Report and Voting result of AGM held on September 29, 2026 · 30 Sept 2026
- Proceeding of AGM held on Tuesday, September 29, 2026 · 30 Sept 2026
- The Company has sent letters to those shareholders whose email addresses are not registered. · 05 Sept 2026
- Notice of AGM and Integrated Annual Report for F.Y. 25-26 · 05 Sept 2026
- 37th AGM of the Company is scheduled to be held on September 29, 2026 through VC/OAVM. · 05 Sept 2026
- The Company has considered and decided to hold AGM of the Company on September 29, 2026 through VC/OAVM. · 29 Aug 2026
